SCHEMBL6173495

SCHEMBL6173495

CC(c1ccncc1NC(=O)c1ccccc1)C1NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNK2 O95069 10/20 0.41
KCNK10 P57789 7/20 0.41
KDM4D Q6B0I6 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
TEK Q02763 1/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
LMNA P02545 1/20 0.35
BRAF P15056 1/20 0.34
PDE2A O00408 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
MAPT P10636 1/20 0.34
GSK3B P49841 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173749 0.92 KCNK2 (0.42) KCNK2KCNK10LMNATRPV1MAPT
SCHEMBL6173116 0.91 KCNK2 (0.38) KCNK2KCNK10TEKBRAFMAPT
SCHEMBL6174079 0.91 KCNK2 (0.45) KCNK2KCNK10LMNAPDE2AMAPT
SCHEMBL6174000 0.89 DCTPP1 (0.35) KCNK2KCNK10LMNAMAPTGAA
SCHEMBL6175146 0.88 LMNA (0.39) KCNK2KCNK10LMNAPDE2A
SCHEMBL6171775 0.87 IGF1R (0.38) TRPV1MAPT
SCHEMBL6174745 0.86 IGF1R (0.34) LMNAPDE2A
SCHEMBL6173990 0.84 IGF1R (0.39) LMNAPDE2A
SCHEMBL6174730 0.84 RXFP1 (0.39) LMNAMAPTGSK3BGAA
SCHEMBL6176639 0.84 OXTR (0.36) LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed